Prenatal Cannabis Exposure and Neurodevelopment: What the New Systematic Review Actually Shows
A July 4, 2026 systematic review examined prenatal cannabis neurodevelopment impact, finding no consistent global cognitive impairment but more behavioral and attention difficulties. The evidence supports cautious counseling during pregnancy. This review…
Endocannabinoid System Research: Cannabis in Prenatal Care
Prenatal cannabis polysubstance use is a significant concern in maternal health research. This study highlights the patterns and risks of cannabis combined with other substances during pregnancy. Understanding these patterns aids clinicians in providing…
Endocannabinoid System Research: Cannabis & Child Development
Peripregnancy cannabis exposure is linked to behavioral and developmental differences in children, with varying effects based on autism spectrum disorder symptoms. This research highlights the importance of understanding maternal cannabis use during…
Endocannabinoid System & Autism: Maternal Cannabis Data
Maternal cannabis use peripregnancy child development risks include behavioral and developmental differences in early childhood. These risks vary depending on the presence of autism spectrum disorder symptoms. Understanding these associations is vital…
Cannabis in Pregnancy: What the Science Actually Shows—and What It Doesn’t
This prenatal cannabis exposure neurodevelopment review synthesizes current evidence on cannabis use during pregnancy and its potential impact on offspring brain development. While animal studies provide mechanistic insights, human data remain…
Study Links Prenatal Cannabis Exposure to Schizophrenia Risk
Emerging research on prenatal cannabis exposure schizophrenia risk reveals biological signatures in placental tissue linked to increased schizophrenia risk in offspring. The placenta mediates fetal neurodevelopment during critical brain formation…
Placental Gene Expression Changes From Prenatal Cannabis Exposure Indicate Schizophrenia Risk
Prenatal cannabis exposure placental gene expression changes may indicate increased schizophrenia risk in offspring. Emerging research shows epigenetic disruptions in placental tissue linked to neurodevelopmental pathways. This highlights the placenta's…
Indiana Lawmakers Miss Deadline, Killing Key Cannabis Bill
Indiana medical cannabis access barriers continue as lawmakers missed a critical deadline, killing a key cannabis reform bill. This failure leaves patients facing ongoing legal and criminal challenges. Surrounding states expand access while Indiana…
Can the Placenta Predict Schizophrenia Risk? Lessons from Prenatal Cannabis Exposure
Emerging research highlights placental genetic markers schizophrenia risk as potential early indicators of neurodevelopmental outcomes. Prenatal cannabis exposure may alter these markers, affecting fetal brain development. Understanding these changes is…
Prenatal Cannabis Exposure Study: 9 Clear Findings
A new prenatal cannabis exposure study used meconium testing and Medicaid claims to examine well-child visits, ED use, and developmental delay coding. The headline is simple: no signal of increased utilization burden, and no higher developmental delay by…